Hyderabad Telangana, India

Kumarswamy Ummiti

This inventor holds 1 USPTO granted patent. Top assignee: Slayback Pharma LLC. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kumarswamy Ummiti. Retrieved from https://idiyas.com/inventor/kumarswamy-ummiti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kumarswamy Ummiti: Innovator in Pharmaceutical Compositions

Introduction

Kumarswamy Ummiti is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of liquid compositions for oral administration.

Latest Patents

Kumarswamy holds a patent for "Liquid pharmaceutical compositions of baclofen for oral administration." This invention relates to stable liquid pharmaceutical compositions of baclofen or its pharmaceutically acceptable salts. The compositions are designed to be stable at concentrations of 5 mg/mL or more, suitable for oral administration, and maintain stability at pH ranges of 5-8 over various storage conditions, including long-term storage.

Career Highlights

Kumarswamy Ummiti is associated with Slayback Pharma LLC, where he continues to innovate in the pharmaceutical sector. His work focuses on enhancing the efficacy and stability of pharmaceutical formulations, contributing to improved patient outcomes.

Collaborations

He collaborates with talented professionals in his field, including Sushant Omprakash Dube and Girish Kumar Jain, to advance research and development in pharmaceutical sciences.

Conclusion

Kumarswamy Ummiti's contributions to liquid pharmaceutical compositions exemplify his commitment to innovation in the healthcare industry. His work not only enhances the stability of medications but also improves the quality of life for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…